Cargando…
Transcription factor Nrf2 as a potential therapeutic target for COVID-19
The coronavirus disease 2019 (COVID-19) is caused by a novel severe acute respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with SARS-COV-2 infection frequently exhibit signs of high oxidative stress and systemic inflammation, which accounts for most of the mortality...
Autores principales: | Wang, Yifan, Ma, Jing, Jiang, Yongfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685020/ https://www.ncbi.nlm.nih.gov/pubmed/36417098 http://dx.doi.org/10.1007/s12192-022-01296-8 |
Ejemplares similares
-
Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics)
por: Hamid, Saima, et al.
Publicado: (2020) -
Potential therapeutic agents against COVID-19: What we know so far
por: Lu, Chih-Chia, et al.
Publicado: (2020) -
Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients
por: Zinovkin, R. A., et al.
Publicado: (2020) -
A potential therapeutic strategy for prostatic disease by targeting the oral microbiome
por: Fang, Cheng, et al.
Publicado: (2020) -
RCAN1 in cardiovascular diseases: molecular mechanisms and a potential therapeutic target
por: Wang, Shuai, et al.
Publicado: (2020)